|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Performance Units | (1) | 02/12/2014 | A | 40,500 | (2) | (2) | Common Stock | 40,500 | $ 0 | 40,500 (3) | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Nader Francois 550 HILLS DRIVE BEDMINSTER, NJ 07921 |
X | President, CEO and Director |
/s/ Francois Nader, by Jill Thompson as attorney-in-fact | 04/18/2014 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Each performance unit represents a contingent right to receive one share of NPS Pharmaceuticals, Inc.'s (the "Issuer") common stock. |
(2) | 100% of these performance units vest on the third anniversary of the date of grant (which is February 13, 2016). |
(3) | On February 13, 2013, the reporting person was granted an aggregate of 121,507 performance units. The performance units vest based on the Issuer's satisfaction of certain performance criteria during each of the years ended December 31, 2013, 2014 and 2015. The performance criteria for the year ended December 31, 2013 were met, resulting 40,500 of the performance units becoming subject to the time vesting criteria described in footnote (2) above. |
Remarks: Exhibit List Exhibit 24 - Power of Attorney |